BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35906163)

  • 1. Sex differences in the characteristics and survival of patients with non-small-cell lung cancer: A retrospective analytical study based on real-world clinical data of the Korean population.
    Jeon DS; Kim JW; Kim SG; Kim HR; Song SY; Lee JC; Ji W; Choi CM; Kim HC;
    Thorac Cancer; 2022 Sep; 13(18):2584-2591. PubMed ID: 35906163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of limited resection vs. inadequate adjuvant therapy in patients with pathologic stage II or III non-small cell lung cancer: results from the Korean Association of Lung Cancer Registry.
    Lee J; Cho JS; Kim YD; Ahn HY; ;
    Ann Palliat Med; 2024 Mar; 13(2):230-239. PubMed ID: 38509646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the Korean Association of Lung Cancer Registry (KALC-R), 2014.
    Choi CM; Kim HC; Jung CY; Cho DG; Jeon JH; Lee JE; Ahn JS; Kim SJ; Kim Y; Choi YD; Suh YG; Kim JE; Lee B; Won YJ; Kim YC
    Cancer Res Treat; 2019 Oct; 51(4):1400-1410. PubMed ID: 30913875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.
    Lim JU; Yeo CD; Rhee CK; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():929-938. PubMed ID: 31118602
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival benefit from immunocheckpoint inhibitors in stage IV non-small cell lung cancer patients with brain metastases: A National Cancer Database propensity-matched analysis.
    Takamori S; Komiya T; Powell E
    Cancer Med; 2021 Feb; 10(3):923-932. PubMed ID: 33340271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proportion and clinical features of never-smokers with non-small cell lung cancer.
    Cho J; Choi SM; Lee J; Lee CH; Lee SM; Kim DW; Yim JJ; Kim YT; Yoo CG; Kim YW; Han SK; Park YS
    Chin J Cancer; 2017 Feb; 36(1):20. PubMed ID: 28179026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015.
    Jeon DS; Kim HC; Kim SH; Kim TJ; Kim HK; Moon MH; Beck KS; Suh YG; Song C; Ahn JS; Lee JE; Lim JU; Jeon JH; Jung KW; Jung CY; Cho JS; Choi YD; Hwang SS; Choi CM; ;
    Cancer Res Treat; 2023 Jan; 55(1):103-111. PubMed ID: 35790197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in population-based survival of stage IV NSCLC due to increased use of chemotherapy.
    Aarts MJ; van den Borne BE; Biesma B; Kloover JS; Aerts JG; Lemmens VE
    Int J Cancer; 2015 Mar; 136(5):E387-95. PubMed ID: 25219898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Small Cell Lung Carcinoma in Women: A Retrospective Cohort Study in Indonesia.
    Sutandyo N; Suratman E
    Acta Med Indones; 2018 Oct; 50(4):291-298. PubMed ID: 30630993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System.
    Wainer Z; Wright GM; Gough K; Daniels MG; Russell PA; Choong P; Conron M; Ball D; Solomon B
    Clin Lung Cancer; 2018 Nov; 19(6):e933-e944. PubMed ID: 30206043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study.
    Sakurai H; Asamura H; Goya T; Eguchi K; Nakanishi Y; Sawabata N; Okumura M; Miyaoka E; Fujii Y;
    J Thorac Oncol; 2010 Oct; 5(10):1594-601. PubMed ID: 20736855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer in women, a different disease: survival differences by sex in Turkey.
    Ulas A; Tokluoglu S; Kos M; Silay K; Akinci S; Oksuzoglu B; Alkis N
    Asian Pac J Cancer Prev; 2015; 16(2):815-22. PubMed ID: 25684531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Factor and Clinical Outcome in Stage III Non-Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population.
    Kim HC; Ji W; Lee JC; Kim HR; Song SY; Choi CM; ;
    Cancer Res Treat; 2021 Oct; 53(4):1033-1041. PubMed ID: 33592139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
    Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
    Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
    Li B; Cui Y; Diehn M; Li R
    JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies.
    Ou SH; Zell JA
    J Thorac Oncol; 2009 Oct; 4(10):1202-11. PubMed ID: 19701111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex and survival in non-small cell lung cancer: A nationwide cohort study.
    Radkiewicz C; Dickman PW; Johansson ALV; Wagenius G; Edgren G; Lambe M
    PLoS One; 2019; 14(6):e0219206. PubMed ID: 31247015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
    Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
    JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.